These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
278 related items for PubMed ID: 20876623
1. Persistent Candida albicans colonization and molecular mechanisms of azole resistance in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) patients. Siikala E, Rautemaa R, Richardson M, Saxen H, Bowyer P, Sanglard D. J Antimicrob Chemother; 2010 Dec; 65(12):2505-13. PubMed ID: 20876623 [Abstract] [Full Text] [Related]
2. Decreased susceptibility of Candida albicans to azole antifungals: a complication of long-term treatment in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) patients. Rautemaa R, Richardson M, Pfaller M, Koukila-Kähkölä P, Perheentupa J, Saxén H. J Antimicrob Chemother; 2007 Oct; 60(4):889-92. PubMed ID: 17704513 [Abstract] [Full Text] [Related]
3. Activity of amphotericin B, anidulafungin, caspofungin, micafungin, posaconazole, and voriconazole against Candida albicans with decreased susceptibility to fluconazole from APECED patients on long-term azole treatment of chronic mucocutaneous candidiasis. Rautemaa R, Richardson M, Pfaller MA, Perheentupa J, Saxén H. Diagn Microbiol Infect Dis; 2008 Oct; 62(2):182-5. PubMed ID: 18597968 [Abstract] [Full Text] [Related]
4. ADH1 expression inversely correlates with CDR1 and CDR2 in Candida albicans from chronic oral candidosis in APECED (APS-I) patients. Siikala E, Bowyer P, Richardson M, Saxen H, Sanglard D, Rautemaa R. FEMS Yeast Res; 2011 Sep; 11(6):494-8. PubMed ID: 21585651 [Abstract] [Full Text] [Related]
8. RTA2, a novel gene involved in azole resistance in Candida albicans. Jia XM, Ma ZP, Jia Y, Gao PH, Zhang JD, Wang Y, Xu YG, Wang L, Cao YY, Cao YB, Zhang LX, Jiang YY. Biochem Biophys Res Commun; 2008 Sep 05; 373(4):631-6. PubMed ID: 18601908 [Abstract] [Full Text] [Related]
9. New evidence that Candida albicans possesses additional ATP-binding cassette MDR-like genes: implications for antifungal azole resistance. Walsh TJ, Kasai M, Francesconi A, Landsman D, Chanock SJ. J Med Vet Mycol; 1997 Sep 05; 35(2):133-7. PubMed ID: 9147273 [Abstract] [Full Text] [Related]
10. Reduced susceptibility of Candida albicans clinical isolates to azoles and detection of mutations in the ERG11 gene. Zhang L, Yang HF, Liu YY, Xu XH, Ye Y, Li JB. Diagn Microbiol Infect Dis; 2013 Dec 05; 77(4):327-9. PubMed ID: 24070847 [Abstract] [Full Text] [Related]
11. Stable azole drug resistance associated with a substrain of Candida albicans from an HIV-infected patient. White TC, Pfaller MA, Rinaldi MG, Smith J, Redding SW. Oral Dis; 1997 May 05; 3 Suppl 1():S102-9. PubMed ID: 9456667 [Abstract] [Full Text] [Related]
16. Emergence of azole drug resistance in Candida species from HIV-infected patients receiving prolonged fluconazole therapy for oral candidosis. Johnson EM, Warnock DW, Luker J, Porter SR, Scully C. J Antimicrob Chemother; 1995 Jan 05; 35(1):103-14. PubMed ID: 7768758 [Abstract] [Full Text] [Related]
17. The synergy of honokiol and fluconazole against clinical isolates of azole-resistant Candida albicans. Jin J, Guo N, Zhang J, Ding Y, Tang X, Liang J, Li L, Deng X, Yu L. Lett Appl Microbiol; 2010 Sep 05; 51(3):351-7. PubMed ID: 20681969 [Abstract] [Full Text] [Related]